Today: November 16, 2018, 8:08 am
  
Business

Crown Bioscience Expands Cardiovascular & Metabolic Disease Research Capability

PR-Inside.com: 2018-11-08 14:01:01

The Company Offers New Non-GLP Services & Translational Rodent Models at its expanded site in Louisiana

SAN DIEGO, Nov. 08, 2018 (GLOBE NEWSWIRE) -- Crown Bioscience, a global drug discovery and development services company providing translational platforms to advance oncology, inflammation, cardiovascular and metabolic disease research, announced the expansion of its New Iberia, Louisiana research facilities to support novel capabilities including non-GLP clinical chemistry, biomarker services and proprietary early stage preclinical models.

With this enhancement CrownBio will focus on cardio-metabolic endpoints to cost effectively deliver robust, high-quality sample analysis data as a standalone service, or as a supplement to in vivo studies, which will provide valuable information about drug efficacy, candidate selection and enzymatic activity.

The Company has also added an electrochemiluminescent technology platform to its on-site research capabilities, allowing clients to investigate the disease pathophysiology and the agents’ mechanism of action.

This expansion follows CrownBio’s 2017 investment at the New Iberia Research Center (NIRC) to house its exclusive FATZO and ZDSD polygenic models for obesity, metabolic syndrome and diabetes translational research, in fully renovated, state-of-the art facilities that benefit from AAALAC, OLAW and USDA accreditations.

“We are incredibly pleased with the outcome of our renovation and expansion,” stated Keefe Chng, General Manager and CSO of CrownBio Louisiana. “The addition of the FATZO and ZDSD preclinical models to our platform at CrownBio Louisiana is a significant step forward in our capabilities at this site.”

“Our clients are thrilled to have access to an analytical lab onsite,” said Jim Wang, Senior Vice President of CrownBio’s Cardiovascular and Metabolic Disease division. “These platforms allow us to rapidly and cost-effectively analyze samples thereby enabling our clients to get their compounds to the clinic sooner.”

To learn more about CrownBio’s new clinical chemistry and biomarker services, visit https://www.crownbio.com/reliable-clinical-chemistry-biomarker-services

About Crown Bioscience Inc.

Crown Bioscience is a global drug discovery and development service company providing translational platforms to advance oncology and metabolic disease research. With an extensive portfolio of relevant models and predictive tools, Crown Bioscience enables clients to deliver superior clinical candidates. 

Media Enquiries:

Jody Barbeau
Crown Bioscience Inc. marketing@crownbio.com




# 508 Words
Related Articles
More From The Author
Groupe Ecore Holding S.A.S. Proposed Senior Secured [..]
Groupe Ecore Holding S.A.S. (the “Issuer”) announces that it intends to offer €255 million in aggregate principal amount [..]
ADC Therapeutics Announces Presentations at the Society [..]
Potential new immune-oncology therapy uses antibody drug conjugate (ADC) that targets regulatory T cells (Tregs) Highly potent [..]
TBC Bank wins the Best Private Bank [..]
TBC Bank has been named the Best Private Bank in Georgia 2018 by Professional Wealth Management (PWM) and The Banker [..]
Merus to Present at the Jefferies 2018 [..]
UTRECHT, The Netherlands, Nov. 08, 2018 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq:MRUS), a clinical-stage immuno-oncology company developing [..]
Vectura Group announces global agreement with Hikma [..]
Vectura Group announces global agreement with Hikma to develop generic versions of GSK’s Ellipta® portfolio  Upfront payment [..]
 
More From Business
NJAWBO Annual Holiday Dinner & Expo for [..]
The New Jersey Association of Women Business Owners (NJAWBO) Annual Statewide Holiday Dinner and Expo will take place on November [..]
Have the coziest living room with Marble [..]
UK – 12th November 2018 – Often times we want our apartmens and houses to be cozier, and thus, more [..]
Huge Success for Iberia Consulting´s B2B Meetings [..]
The annual Eurasia Packaging Fair is a 4-day event that started on the 31st of October until the 3rd of [..]
Revelation Creative Certified by the Women’s Business [..]
Revelation Creative, a business specializing in digital marketing, web and print design, and branding, is proud to announce national [..]
Why Unified Acquires UK Payment Processor, Verified [..]
Why Unified, the Tampa, Florida sales and marketing platform has announced a pending acquisition of Verified Payments, a UK [..]

Disclaimer: If you have any questions regarding information in this press release please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims the content included in this release.